GlassScriptPhysician profile
Amber Gudas
NPI 1174899017
$3,614.77
in general payments reported to CMS, 2019-2025
10 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,630 · 2023: $125 · 2024: $744 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $985.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $984.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,629.89 | 2021 | |
| Abbvie INC. | $326.98 | 2023-2025 | |
| Genzyme Corporation | $186.35 | 2024 | |
| Novartis Pharmaceuticals Corporation | $152.98 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $122.93 | 2023-2024 | Ilumya |
| Amgen INC. | $112.04 | 2023-2025 | Otezla, Otezla |
| Incyte Corporation | $28.45 | 2024 | Opzelura |
| Solta Medical, A Division of Bausch Health US, LLC | $24.35 | 2024 | |
| Fidia Pharma USA INC. | $16.88 | 2024 | |
| Merz North America, INC. | $13.92 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Gudas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.